Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Xiao Fang Pharmaceutical CoSHSE:603207 +1.72%38 Dividend Yield % is 4.90% as of Jul. 27, 2026, which is 32% below its 10-year median of 7.25. GuruFocus rates SHSE:603207 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 514 Drug Manufacturers companies, Shanghai Xiao Fang Pharmaceutical Co ranks better than 86.58% on this metric.
SHSE:603207'
s Dividend Yield % Range Over the Past 10 Years
Min: 4.06 Med: 7.25 Max: 10.23
Current: 4.9
During the past 7 years, the highest Dividend Yield of Shanghai Xiao Fang Pharmaceutical Co was 10.23%. The lowest was 4.06%. And the median was 7.25%.
SHSE:603207's Dividend Yield % is ranked better than 86.58% of 514
companies
in the Drug Manufacturers industry
Industry Median: 1.96
vs SHSE:603207: 4.90
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shanghai Xiao Fang Pharmaceutical Co Ltd is 1.73, which seems too high.
During the past 7 years, the highest Dividend Payout Ratio of Shanghai Xiao Fang Pharmaceutical Co was 1.73. The lowest was 1.71. And the median was 1.71.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xiao Fang Pharmaceutical Co Dividend Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Xiao Fang Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Xiao Fang Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Xiao Fang Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Shanghai Xiao Fang Pharmaceutical Co's Dividend Yield % falls into.
Shanghai Xiao Fang Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Shanghai Xiao Fang Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.370000
2026-07-03
2026-07-02
2026-07-03
Cash Dividend
semi-annually
CNY:CNY 1.000000
CNY 0.700000
2025-10-20
2025-10-17
2025-10-20
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a Dividend Yield % of 4.90% as of Jul. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. This is 32% below median its historical median of 7.25. Over the past decade, Shanghai Xiao Fang Pharmaceutical Co's Dividend Yield % has ranged from 4.06 to 10.23. According to the industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #69 out of 514 companies in the Drug Manufacturers industry, placing it in the top 13.4%.
Is Shanghai Xiao Fang Pharmaceutical Co's Dividend Yield % too high?
Shanghai Xiao Fang Pharmaceutical Co's current Dividend Yield % of 4.90% is 32% below median its 10-year median of 7.25. Over the past 10 years, this metric has ranged from a low of 4.06 to a high of 10.23. The Drug Manufacturers industry median Dividend Yield % is 1.96. Shanghai Xiao Fang Pharmaceutical Co's value of 4.90% is 150% above this industry median. Based on the distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #69 out of 514 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Xiao Fang Pharmaceutical Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xiao Fang Pharmaceutical Co's Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #69 out of 514 companies for Dividend Yield %. This places Shanghai Xiao Fang Pharmaceutical Co in the top 13% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.96. Shanghai Xiao Fang Pharmaceutical Co's value of 4.90% is 150% above this benchmark. Historically, Shanghai Xiao Fang Pharmaceutical Co's own Dividend Yield % has ranged from 4.06 to 10.23 over the past decade. While the company's 10-year median is 7.25 vs. the industry median of 1.96, Shanghai Xiao Fang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.96, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Xiao Fang Pharmaceutical Co's current Dividend Yield % of 4.90% is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Xiao Fang Pharmaceutical Co's current Dividend Yield % is 4.90%, which is 32% below median its own 10-year median of 7.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xiao Fang Pharmaceutical Co stock overvalued right now?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a current Dividend Yield % of 4.90%. The current Dividend Yield % is 4.90%, which is 32% below median its 10-year median of 7.25 and 150% above the Drug Manufacturers industry median of 1.96. Shanghai Xiao Fang Pharmaceutical Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207), the current Dividend Yield % is 4.90% as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanghai Xiao Fang Pharmaceutical Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603207 has been successfully added to your 
